BMO Capital Downgrades Pfizer To Market Perform, Shares Drop By: Benzinga via Benzinga July 28, 2014 at 07:23 AM EDT BMO Capital downgraded Pfizer (NYSE: PFE) from Outperform to Market Perform. The target price for Pfizer has been lowered from $34 ... Read More >> Related Stocks: Pfizer